My brother Alan had an article published in the February 14th issue of The New England Journal of Medicine. We're all proud of him.

The article title: Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer. As with all brilliant ideas, the conclusion of the article seem self-evident upon further reflection, I mean clearly you'd anticipate selumetinib producing clinically meaningful increases in iodine uptake and retention in a subgroup of patients with thyroid cancer that is refractory to radioiodine, it's amazing we never believed this before, ahhh, I have no idea what I'm talking about, why am I not smart enough, my life has no meaning.